Sherry Shen

Sherry Shen practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Sherry Shen's NPI, 1942662127, was assigned on March 25, 2016. Sherry Shen graduated from Columbia University College of Physicians and Surgeons in 2016. Sherry Shen holds New York license 291331.

Sherry Shen's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Sherry Shen's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center at Basking Ridge New Jersey. Dmand AI also links Sherry Shen to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sherry Shen practices. Vendor and product names are available with a free account.

Hematology and oncology is Sherry Shen's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Sherry Shen is licensed in New York.

CMS data shows 223 Medicare services from Sherry Shen across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $19,600 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw Sherry Shen in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have cancer, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sherry Shen's median patient age at 67, with 95% women.

In 2024, Sherry Shen wrote 337 Medicare Part D claims for 85 patients. 80% of them were for generic drugs. CMS names the drug for 255 of them, across 5 drugs with 11 or more claims each, at $560,579 in total drug cost. In 2023, CMS named 134 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Sherry Shen for performance year 2024, reported as part of a group. Sherry Shen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sherry Shen as offering telehealth.

Dmand AI links 18 papers to Sherry Shen, published from 2013 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Body Mass Index. Sherry Shen has published most often in NPJ Breast Cancer. Sherry Shen's most frequent co-authors are Neil Mukund Iyengar, MD, Katherine D. Crew, MD, MS and Dawn Lauryn Hershman, MD.

CMS Open Payments shows 25 general payments to Sherry Shen from 7 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 45% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,159. It also lists 2 research payments totaling $827 from 2024 to 2025.

Sherry Shen graduated from Columbia University College of Physicians and Surgeons in 2016.